Literature DB >> 30542764

Survival analysis of distant metastasis of laryngeal carcinoma: analysis based on SEER database.

Yafeng Pan1, Yuming Hong1, Zhenyuan Liang1, Wei Zhuang2.   

Abstract

BACKGROUND: The purpose of this study was to investigate the prognostic factors and the value of surgical treatment of patients with newly diagnosed laryngeal cancer with distant metastasis (DM).
METHODS: The Surveillance, Epidemiology and End Result database (SEER) was used to analyze 446 patients with laryngeal cancer with DM at the time of initial diagnosis from 2010 to 2014.The survival prognosis of patients with DM was performed by using Kaplan-Meier and log-rank test. The prognostic factors and the effect of surgery were analyzed using the Cox regression analysis and R-language data package.
RESULTS: The incidence of DM was 3.21% (446/13865). Lung was the most common distant metastatic site of laryngeal cancer (62.6%), and brain metastases had the worst prognosis in patients at 2 months. T stage and brain metastasis were independent risk factors affecting the survival (P < 0.05). The hazard ratio (HR) of DM in T4 stage was nearly twice than that in T1 stage. Surgical treatment of primary and metastatic tumors can cause better survival for patients. Patients who didn't underwent primary tumor surgery were approximately twice as likely to die from cancer as those who did. The nomogram model was constructed to visually present the 1-, 2- and 3-year survival rates of patients.
CONCLUSIONS: T stage, brain metastasis and surgical treatment are prognostic factors of patients with M1 stage laryngeal cancer. Surgical treatment of primary tumors and metastases can lead to better survival for patients. TRIAL REGISTRATION: Not applicable.

Entities:  

Keywords:  Distant metastasis; Laryngeal cancer; Prognosis; SEER; Surgical treatment

Mesh:

Year:  2018        PMID: 30542764     DOI: 10.1007/s00405-018-5244-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.

Authors:  Wenfei Li; Min Fu; Kun Zhao; Fang Han; Ning Bu; Zhanqiu Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-27       Impact factor: 2.503

2.  Dihydroartemisinin inhibits IL-6-induced epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway.

Authors:  Yajing Sun; Xiuying Lu; Hui Li; Xiaoming Li
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

3.  A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.

Authors:  Jie Cui; Qingquan Wen; Xiaojun Tan; Zhen Chen; Genglong Liu
Journal:  Dis Markers       Date:  2019-11-20       Impact factor: 3.434

4.  Tonic-clonic seizures as first symptom of a disseminated supraglottic laryngeal cancer.

Authors:  Christian Danstrup; Maria Andersen
Journal:  BMJ Case Rep       Date:  2020-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.